Exclusive: Facing chips shortage, Biden may shelve blunt tool used in
COVID fight
Send a link to a friend
[May 05, 2021]
By Andrea Shalal, Trevor Hunnicutt and David Shepardson
WASHINGTON (Reuters) - Some critical
industries could suffer if the U.S. government uses a national security
law to redirect scarce computer chips to the auto industry, a senior
administration official told Reuters.
The analysis suggests the White House could opt to reject calls to
invoke the Defense Production Act by automakers and a bipartisan set
of U.S. lawmakers.
Numerous automakers have been forced to slow or pause production due to
a lack of semiconductors and have spoken with the White House about
possibly using the 1950 law that allows the government to force
companies to produce materials for national security reasons.
Still, many auto industry officials said privately they do not think
invoking the act would be feasible or likely.
Asked whether using the law was a possibility, the administration
official said "the short-term outlook is challenging."
Reallocating semiconductors to automakers "would result in fewer chips
for others," the official, who is involved in high-level discussions on
the issue, told Reuters. Such a move could hurt makers of consumer
electronics such as laptops and medical devices like pacemakers, the
official added.
"This is the worst nightmare if you're a supply chain manager," said
another person familiar with the White House's thinking. "As a nation,
it's terrible."
No final decisions have been made, people familiar with the matter said.
The official said the administration is pushing chips users and
producers to increase transparency by improving the capacity to forecast
demand and generating better information on how chips are moving through
supply chains to end users.
The administration plans to issue recommendations once it completes a
100-day review required under a February executive order by Biden,
including ways to "incentivize and encourage production at home and
surge capacity," the official said.
The review is looking at supply chains for semiconductors, high capacity
batteries, critical minerals and pharmaceuticals and active
pharmaceutical ingredients.
[to top of second column]
|
President Joe Biden delivers remarks on the state of the coronavirus
disease (COVID-19) vaccinations from the State Dining Room at the
White House in Washington, D.C., U.S., May 4, 2021. REUTERS/Jonathan
Ernst
Biden used the Korean War-era law to boost vaccines
and critical medical equipment supplies to fight the COVID-19
pandemic. The chips issue threatens the U.S. economy and imperils
jobs in election battlegrounds from Texas to Michigan.
Last week, Ford Motor Co warned the chip shortage will slash
second-quarter production by 50%. Biden has asked Congress for $50
billion to bolster the domestic chips industry and $50 billion to
create a new Commerce Department office to monitor domestic
industrial capacity.
U.S. Senator Chris Coons of Delaware, who had urged use of the
Defense act, said he was "pleased" with the administration's actions
so far.
Washington has been appealing to Taiwan and other foreign
governments to boost chip production levels for U.S. buyers, said
the official. The administration is considering regulatory options
and possible multilateral agreements to avert future crises, the
person said.
Taiwan Semiconductor Manufacturing Co Ltd (TSMC) is looking to build
more U.S. chipmaking factories in Arizona beyond one already
planned, Reuters reported.
Industry data show U.S. manufacturers only account for about 12% of
worldwide semiconductor manufacturing capacity, down from 37% in
1990. More than 80% of chip production happens in Asia.
"There's no quick fix," said Chad Bown, a senior fellow at the
Peterson Institute for International Economics.
(Reporting by Andrea Shalal, Trevor Hunnicutt and David Shepardson;
Editing by Chris Sanders and David Gregorio)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |